Royal Marsden Nhs Foundation Trust

This study tested whether adding radiotherapy to the drug pembrolizumab works better than pembrolizumab alone for people with advanced melanoma. The goal was to see if the combination could slow cancer growth and even shrink tumors that were not directly treated. The trial was st…

This early-phase trial tested whether combining the immunotherapy drug pembrolizumab with precise, high-dose radiation (SBRT) could help people with advanced malignant pleural mesothelioma, a rare cancer of the lung lining. The study aimed to enroll up to 18 adults whose cancer h…

This early-phase study tested whether adding the immunotherapy drug pembrolizumab to standard chemoradiotherapy is safe for people with stage IV head and neck cancer. Only 3 participants were enrolled before the study was stopped. The main goal was to find the highest safe dose a…